19-Nov-2026 13:32:20

ALKEMGeneral news

ALKEM : RECEIVES US FDA WARNING LETTER FOR AMALIYA DAMAN FACILITY

• US FDA issued warning letter dated November 18, 2026 for the Amaliya, Daman manufacturing facility • Follows inspection held April 20 to May 1, 2026, which was classified as Official Action Indicated (OAI) • Warning letter requires implementation of corrective and preventive actions to address observations and prevent recurrence • Company to respond to the US FDA within the stipulated timeline • Company continues to manufacture and supply approved products from the facility to the US market • Company says there is no material impact on current operations, financial or other activities

Alkem Laboratories Ltd

Open attachment

← Back to feed